EXE — Extendicare Income Statement
0.000.00%
Last trade - 00:00
- CA$611.20m
- CA$870.53m
- CA$1.30bn
- 82
- 76
- 89
- 96
R2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,132 | 1,104 | 1,167 | 1,222 | 1,305 |
Cost of Revenue | |||||
Gross Profit | 133 | 181 | 133 | 109 | 151 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,082 | 1,015 | 1,132 | 1,210 | 1,245 |
Operating Profit | 50.3 | 88.7 | 34.7 | 11.9 | 60.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 22 | 58.7 | 14 | -4.5 | 44.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 14.8 | 42.5 | 7.5 | -4.51 | 34 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 28.6 | 54.2 | 11.5 | 69.6 | 34 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 28.6 | 54.2 | 17.7 | 75.8 | 34 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.184 | -0.149 | 0.123 | 0.122 | 0.424 |
Dividends per Share |